/
Metabolic & Endocrine
Metabolic Syndrome
37
Pipeline Programs↗
33
Active Trials↗
30
Companies Involved↗
Metabolic Syndrome is a moderately active landscape with 37 programs across 30 companies. The most active players are Novo Nordisk. 1 program is in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical33
Phase 12
Approved
No programs
Analysis
Modality Breakdown
97%
Small molecule
36 of 37 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 37 classified programs, each share of the total. Modality classified for 100% of 37 pipeline programs.
Analysis
Trial Status
223
clinical trials
Completed140 · 63%
Unknown status25 · 11%
Recruiting16 · 7%
Terminated16 · 7%
Not yet recruiting11 · 5%
Withdrawn6 · 3%
Other9 · 4%
Clinical Trials
Trial Activity
223 trials
A Randomized Study to Compare the Effect of a Healthy Beef-Centric Diet to a Healthy U.S.-Style Dietary Pattern on Inflammation and Other Metabolic Health Outcomes in a Metabolic Syndrome and/or Pre-Diabetic Population
Recruiting·NNational Cattlemen's Beef Association, a contractor to the Beef Checkoff·Preclinical·NCT07269847·56 enrolled
Circadian Rhythms in Postmenopausal Women
Recruiting·—·Preclinical·NCT04893226·164 enrolled
Page 1 of 15
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)